France· FR:60578560
ALDOMET 250 mg, comprimé enrobé
A methyldopa product, registered in France by HAC PHARMA, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- HAC PHARMA
- Country
- France (FR)
- ATC code
- C02AB
- ATC class
- Methyldopa
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930021989plaquette(s) PVC-Aluminium de 30 comprimé(s)EUR 3.01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ALDOMET in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAldomet 250mg tabletsAspen Pharma Trading Ltd
- PolandDopegytDelfarma Sp. z o.o.
- NetherlandsL-Methyldopa Teva 125 mg, omhulde tablettenTeva Nederland B.V.
- United StatesMethyldopaChartwell RX, LLC
- GermanyDopegytCheplapharm Arzneimittel Gmbh
- CanadaMETHYLDOPAAA PHARMA INC
- NorwayAldometAspen Global Health and Development
- FinlandMethyldopa MacureMacure Pharma ApS
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Aldometil
- Belgium · Aldomet
- Bulgaria · Допегит
- Cyprus · Dopamet, Methyldopa Remedica
- Czechia · Dopegyt
- Germany · Dopegyt, Methyldopa Stada
- Denmark · Methyldopa Macure
- Spain · Aldomet, Aldomet Forte
- Finland · Methyldopa Macure
- United Kingdom (Northern Ireland) · Methyldopa, Methyldopa Accord-Uk
- Hungary · Dopegyt
- Italy · Aldomet
- Lithuania · Dopegyt
- Latvia · Dopegyt
- Malta · Methyldopa Remedica
- Netherlands · L-Methyldopa Teva, Methyldopa Cf
- Norway · Methyldopa Macure
- Poland · Dopegyt
- Portugal · Aldomet, Aldomet Forte
- Romania · Dopegyt
- Sweden · Methyldopa Macure
- Slovakia · Dopegyt
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e34001b1-c800-49c9-adcc-74327e0f3269 GET /v1/drugs/e34001b1-c800-49c9-adcc-74327e0f3269?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60578560",
"date_amm": "1990-08-29",
"type_amm": "Procédure nationale",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé enrobé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ALDOMET.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.